Glenmark Specialty SA
Pharmaceuticals / Pharmaceutical ManufacturingPatients requiring specialized treatments for respiratory, dermatology, and oncology conditions.
Glenmark Specialty SA is a Swiss AG registered in Neuchâtel, NE. Its registered activity falls under Manufacture of pharmaceutical preparations.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~14,000 (group wide)Officers24Active Relations23Deleted Relations0SOGC Records34First Record17.04.2015Latest Activity08.04.2026PharmaceuticalsOncologyRespiratoryDermatologyBiotechSpecialty Pharma
Registry Information
- Swiss UID
- CHE-161.461.744
- Legal Name
- Glenmark Specialty SA
- Legal Form
- Limited
- Incorporated
- 17 Apr 2015
- Share Capital
- 30'000'000 d'actions de CHF 1, nominatives, liées selon statuts
- Canton
- NE
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Manufacture of pharmaceutical preparations
CMANUFACTURING21Manufacture of basic pharmaceutical products and pharmaceutical preparations212Manufacture of pharmaceutical preparations2120Manufacture of pharmaceutical preparations212000
Industry Health
Registered Address
Rue du Puits-Godet 8, 2000 Neuchâtel
2000, Neuchâtel, NE
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Auditor
Has auditorGrant Thornton AG
Since
Current Directors & Officers
From the web
Target Customers
Patients requiring specialized treatments for respiratory, dermatology, and oncology conditions.
Competitors (1)
Glenmark Pharmaceuticals competitors
Global pharmaceutical companies including Teva, Sun Pharma, Cipla, Dr. Reddy's, and Lupin.
Sources (5)
Glenmark Pharmaceuticals
glenmarkpharma.com
Glenmark Pharma signs $18 mn deal with Hengrui for cancer therapy drug | Company News - Business Standard
business-standard.com
Glenmark Specialty SA - Drug pipelines, Patents, Clinical trials - Synapse
synapse.patsnap.com
Company Data Summary Report Of Glenmark Specialty Sa
chemxpert.com
https://glenmarkpharma.com/press_release/glenmark-specialty-sa-receives-u-s-fda-approval-for-fluticasone-propionate-inhalation-aerosol-usp-44-mcg-per-actuation-with-180-day-competitive-generic-therapy-exclusivity/
glenmarkpharma.com